Weijing Cai

11.6k total citations · 3 hit papers
117 papers, 9.2k citations indexed

About

Weijing Cai is a scholar working on Clinical Biochemistry, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Weijing Cai has authored 117 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Clinical Biochemistry, 31 papers in Oncology and 29 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Weijing Cai's work include Advanced Glycation End Products research (57 papers), Lung Cancer Treatments and Mutations (24 papers) and Natural Antidiabetic Agents Studies (21 papers). Weijing Cai is often cited by papers focused on Advanced Glycation End Products research (57 papers), Lung Cancer Treatments and Mutations (24 papers) and Natural Antidiabetic Agents Studies (21 papers). Weijing Cai collaborates with scholars based in United States, China and Australia. Weijing Cai's co-authors include Helen Vlassara, Jaime Uribarri, Li Zhu, Gary E. Striker, Μelpomeni Peppa, Teresia Goldberg, John Cijiang He, Renata Pyzik, Susan Goodman and Xue Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Oncology.

In The Last Decade

Weijing Cai

116 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet

2010 948 citations Jaime Uribarri, Weijing Cai et al. profile →
Advanced glycoxidation end products in commonly consumed foods

2004 586 citations Teresia Goldberg, Weijing Cai et al. profile →
Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

2002 545 citations Helen Vlassara, Weijing Cai et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weijing Cai United States	52	5.2k	3.4k	2.0k	1.6k	1.3k	117	9.2k
Masayoshi Takeuchi Japan	62	7.3k 1.4×	5.0k 1.5×	1.8k 0.9×	2.8k 1.8×	1.8k 1.4×	256	12.4k
Daisuke Koya Japan	75	2.4k 0.5×	4.1k 1.2×	3.6k 1.8×	6.6k 4.3×	1.1k 0.8×	292	18.9k
Takanori Matsui Japan	54	4.3k 0.8×	3.7k 1.1×	1.1k 0.6×	2.3k 1.4×	833 0.6×	252	9.2k
Karin Jandeleit‐Dahm Australia	57	2.2k 0.4×	2.4k 0.7×	1.8k 0.9×	3.7k 2.4×	538 0.4×	157	10.8k
Susan Hama United States	53	4.6k 0.9×	3.6k 1.1×	806 0.4×	2.8k 1.8×	200 0.2×	75	12.9k
Melinda T. Coughlan Australia	43	2.7k 0.5×	1.8k 0.5×	1.3k 0.7×	2.1k 1.4×	572 0.4×	97	6.7k
Maria F. Lopes‐Virella United States	54	1.1k 0.2×	3.1k 0.9×	1.1k 0.6×	2.1k 1.3×	301 0.2×	225	10.7k
Anatol Kontush France	55	1.3k 0.3×	4.6k 1.4×	1.6k 0.8×	3.0k 2.0×	299 0.2×	163	11.7k
Naila Rabbani United Kingdom	50	3.8k 0.7×	1.8k 0.5×	1.6k 0.8×	2.4k 1.5×	869 0.7×	130	7.1k
Diana M. Shih United States	49	4.0k 0.8×	912 0.3×	1.5k 0.8×	3.2k 2.1×	242 0.2×	80	9.6k

Countries citing papers authored by Weijing Cai

Since Specialization

Citations

This map shows the geographic impact of Weijing Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijing Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijing Cai more than expected).

Fields of papers citing papers by Weijing Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijing Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijing Cai. The network helps show where Weijing Cai may publish in the future.

Co-authorship network of co-authors of Weijing Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Weijing Cai. A scholar is included among the top collaborators of Weijing Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijing Cai. Weijing Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, H. J., Biao Zhang, Wenyan Guan, et al.. (2023). Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes. Cancer Medicine. 12(9). 10575–10586. 5 indexed citations

Lotan, Roni, Ithamar Ganmore, Abigail Livny, et al.. (2021). Design and Feasibility of a Randomized Controlled Pilot Trial to Reduce Exposure and Cognitive Risk Associated With Advanced Glycation End Products in Older Adults With Type 2 Diabetes. Frontiers in Nutrition. 8. 614149–614149. 6 indexed citations

Biruete, Annabel, Kalisha O’Neill, Colby J. Vorland, et al.. (2020). Adverse Effects of Autoclaved Diets on the Progression of Chronic Kidney Disease and Chronic Kidney Disease-Mineral Bone Disorder in Rats. American Journal of Nephrology. 51(5). 381–389. 5 indexed citations

Chen, Hualin, Meilian Liu, Zhiwei Dai, et al.. (2020). Concomitant genetic alterations are associated with response to EGFR targeted therapy in patients with lung adenocarcinoma. Translational Lung Cancer Research. 9(4). 1225–1234. 13 indexed citations

Cao, Rui, Fan Yang, Si-Cong Ma, et al.. (2020). Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer. Theranostics. 10(24). 11080–11091. 163 indexed citations

Wang, Na, Weiguang Gu, Yuan Qiu, et al.. (2020). Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma. Translational Lung Cancer Research. 9(3). 629–638. 9 indexed citations

Cai, Weijing, Ranjala Ratnayake, Michael H. Gerber, et al.. (2018). Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model. Investigational New Drugs. 37(2). 364–374. 24 indexed citations

Li, Huilin, Weijia Zhang, Fang Zhong, et al.. (2018). Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury. Kidney International. 94(6). 1160–1176. 24 indexed citations

Cai, Weijing, Susan Matthew, Qi-Yin Chen, Valerie J. Paul, & Hendrik Luesch. (2018). Discovery of new A- and B-type laxaphycins with synergistic anticancer activity. Bioorganic & Medicinal Chemistry. 26(9). 2310–2319. 33 indexed citations

10.

Cai, Weijing, Caicun Zhou, Chunxia Su, et al.. (2017). MA15.03 The Predictive Value of Mutation/Neoantigen Burden from ctDNA on the Efficacy of PD-1 Blockade in Advanced NSCLC. Journal of Thoracic Oncology. 12(1). S429–S430. 2 indexed citations

11.

Dai, Yan, Anqun Chen, Ruijie Liu, et al.. (2017). Retinoic acid improves nephrotoxic serum–induced glomerulonephritis through activation of podocyte retinoic acid receptor α. Kidney International. 92(6). 1444–1457. 29 indexed citations

12.

Ren, Shengxiang, Caicun Zhou, Guanghui Gao, et al.. (2017). MA04.03 Preliminary Results of a Phase II Study about the Efficacy and Safety of Pyrotinib in Patients with HER2 Mutant Advanced NSCLC. Journal of Thoracic Oncology. 12(1). S359–S359. 9 indexed citations

13.

Zhou, Caicun & Weijing Cai. (2016). Intratumoral heterogeneity and EGFR-TKIs resistance. Journal of Thoracic Oncology. 11(2). S15–S15. 1 indexed citations

14.

Vlassara, Helen, Weijing Cai, Renata Pyzik, et al.. (2016). Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial. Diabetologia. 59(10). 2181–2192. 108 indexed citations

15.

Cai, Weijing, Jaime Uribarri, Li Zhu, et al.. (2014). Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proceedings of the National Academy of Sciences. 111(13). 4940–4945. 138 indexed citations

16.

Patel, Raza, Susan S. Baker, Wensheng Liu, et al.. (2012). Effect of Dietary Advanced Glycation End Products on Mouse Liver. PLoS ONE. 7(4). e35143–e35143. 80 indexed citations

17.

Cai, Weijing, John Cijiang He, Li Zhu, et al.. (2007). AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66^shc-dependent FKHRL1 phosphorylation. American Journal of Physiology-Cell Physiology. 294(1). C145–C152. 96 indexed citations

18.

Cai, Weijing, Li Zhu, Xue Chen, Jaime Uribarri, & Μelpomeni Peppa. (2006). Association of Advanced Glycoxidation End Products and Inflammation Markers with Thrombosis of Arteriovenous Grafts in Hemodialysis Patients. American Journal of Nephrology. 26(2). 181–185. 9 indexed citations

19.

Uribarri, Jaime, Μelpomeni Peppa, Weijing Cai, et al.. (2003). Restriction of Dietary Glycotoxins Reduces Excessive Advanced Glycation End Products in Renal Failure Patients. Journal of the American Society of Nephrology. 14(3). 728–731. 268 indexed citations

20.

Zheng, Feng, Cijiang He, Weijing Cai, et al.. (2002). Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes/Metabolism Research and Reviews. 18(3). 224–237. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact